Rethinking Uncomplicated UTIs: A Comprehensive Review of Diagnosis, Management, and Novel and Emerging Treatment Options | Webcast
1.0 AMA PRA Credits
Overview
Learning Objectives
CME/ Information
Faculty and Disclosures
Instructions
Program Overview
The high prevalence and clinical impact of uncomplicated urinary tract infections (uUTIs)—along with rising antimicrobial resistance and recent therapeutic advances—underscore the need for timely diagnosis, evidence-based treatment, and optimized patient care.
To ensure appropriate management, healthcare providers must remain current on UTI classification, presenting symptoms, diagnostic workups, and guideline-recommended antibiotic selection informed by local resistance patterns. Keeping pace with emerging resistance trends and newly approved therapies is essential to preserving treatment efficacy and improving outcomes.
Join us for this live, case-based webcast on Friday, September 12 at 12:30 PM ET, led by Matt T. Rosenberg, MD, as we explore practical strategies to enhance diagnostic accuracy, promote antimicrobial stewardship, and strengthen patient-provider communication.
Registration is required to attend—secure your spot today. If you’re unable to join live, a replay will be available to all registered participants.
To ensure appropriate management, healthcare providers must remain current on UTI classification, presenting symptoms, diagnostic workups, and guideline-recommended antibiotic selection informed by local resistance patterns. Keeping pace with emerging resistance trends and newly approved therapies is essential to preserving treatment efficacy and improving outcomes.
Join us for this live, case-based webcast on Friday, September 12 at 12:30 PM ET, led by Matt T. Rosenberg, MD, as we explore practical strategies to enhance diagnostic accuracy, promote antimicrobial stewardship, and strengthen patient-provider communication.
Registration is required to attend—secure your spot today. If you’re unable to join live, a replay will be available to all registered participants.
Thank you!
You have successfully registered for our Rethinking Uncomplicated UTIs: A Comprehensive Review of Diagnosis, Management, and Novel and Emerging Treatment Options Live Webcast.
We look forward to seeing you there.
Target Audience
This educational initiative is designed for primary care physicians, physician assistants, nurse practitioners, nurses and other healthcare professionals in primary care.
Supporter Acknowledgement
This educational activity is supported by an independent educational grant from GSK.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Apply evidence-based guidelines to accurately interpret signs, symptoms, and laboratory test results for diagnosing uUTIs.
- Utilize evidence-based guidelines in selecting antimicrobial therapy for uncomplicated UTIs, thereby minimizing unnecessary antibiotic use.
- Review the key factors contributing to treatment failure in patients with uncomplicated urinary tract infections.
- Evaluate the impact of uUTI and treatment failure on patient well-being.
- Integrate patient education and shared decision-making into their management of uUTIs.
Accredited Provider
This activity is jointly provided by Global Education Group and Iridium Continuing Education.


Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Designation Statement
Global Education Group designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity for 1.0 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Faculty, Staff, and Planners’ Disclosures
Global
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
Iridium
The planners and managers at Iridium have no relevant financial relationships to disclose.
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
Iridium
The planners and managers at Iridium have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Matt T. Rosenberg, MD
Director, Mid Michigan Health Centers
Jackson, MI
Disclosures
Nothing to disclose
Jackson, MI
Disclosures
Nothing to disclose
Instructions to Receive Credit
In order to receive credit for this activity, the participant must:
A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.
For the best user experience, this activity should be completed on a computer,
not on a mobile device.
- Read the learning objectives and faculty disclosures
- Complete the pretest
- Attend the webcast
- Complete the posttest with a score of 70% or higher
- Complete the evaluation
A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.
For the best user experience, this activity should be completed on a computer,
not on a mobile device.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com
System Requirements

Copyright © 2025
Legal



Stay Informed
To receive updates as soon as the new dates are confirmed, please share your email.
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
Thank you!